No Data
No Data
Longeveron Inc. CEO Wa'el Hashad to Present at Biotech Showcase 2025 on January 14
Longeveron Initiated With a Buy at Roth MKM
H.C. Wainwright Maintains Longeveron(LGVN.US) With Buy Rating, Cuts Target Price to $10
Longeveron Initiated at Buy by Roth MKM
Longeveron Price Target Announced at $10.00/Share by Roth MKM
Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024
GoldenRam : comatose ? hope they can find a cure for eomething soon.
74234152 : I see something
74234152 : The CEO HASHAD use to have a senior position at a few big companies including Eli Lilly this stock will go up PT 10 it loooks to me that it is about to break out he presents Jan 14 when he joined the company earlier in the year the stock had a bounce look for yourself
browny_440 : looks promising